Now showing items 1-12 of 12

    • A Multifaceted Approach to Pulmonary Hypertension in Adults With Congenital Heart Disease. 

      Krasuski, Richard; Fathallah, Mouhammad (Progress in cardiovascular diseases, 2018-09)
      Advances in the management of congenital heart disease (CHD) in children have resulted in growing numbers of adults with CHD. Pulmonary arterial hypertension related to CHD (PAH-CHD) is a common complication, affecting up ...
    • Association of anemia and long-term survival in patients with pulmonary hypertension. 

      Bashore, TM; Harrison, JK; Hart, Stephen A; Krasuski, Richard Andrew; Smith, Bradley; Wang, Andrew (Int J Cardiol, 2011-08-04)
      BACKGROUND: Anemia is a marker of worsened clinical outcome in patients with heart failure from left ventricular dysfunction. Pulmonary hypertension often results in right ventricular dysfunction. Accordingly we sought to ...
    • Congenital heart disease and pulmonary hypertension. 

      Gupta, V; Krasuski, Richard Andrew; Tonelli, AR (Heart Fail Clin, 2012-07)
      Many patients with congenital heart disease and systemic-to-pulmonary shunts develop pulmonary arterial hypertension (PAH), particularly if the cardiac defect is left unrepaired. A persistent increase in pulmonary blood ...
    • Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension. 

      Batal, O; Dweik, RA; Faulx, M; Hammel, JP; Hussein, AA; Khatib, OF; Krasuski, Richard Andrew; ... (8 authors) (Am J Cardiol, 2012-09-15)
      Brain natriuretic peptide (BNP) levels are lower in obese patients with left ventricular failure than in their comparably ill, leaner counterparts. The effect of obesity on BNP in patients with pulmonary arterial hypertension ...
    • In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. 

      Hornik, Christoph; Smith, Phillip; Messina, Julia; Jackson, W; Guglielmo, K; Watwe, A; Delancy, G; ... (12 authors) (Journal of perinatology : official journal of the California Perinatal Association, 2017-07)
      OBJECTIVE:To characterize in-hospital outcomes of premature infants diagnosed with severe bronchopulmonary dysplasia (BPD). STUDY DESIGN:Retrospective cohort study including premature infants with severe BPD discharged from ...
    • Partial anomalous pulmonary venous connection and pulmonary arterial hypertension. 

      Krasuski, Richard Andrew; Sahay, S; Tonelli, AR (Respirology, 2012-08)
      BACKGROUND AND OBJECTIVE: Isolated partial anomalous pulmonary venous connection (PAPVC) has been implicated as a cause of pulmonary arterial hypertension (PAH); however this condition is often overlooked in the diagnostic ...
    • Pharmacologic management of perioperative pulmonary hypertension. 

      Cheng, JW; Krasuski, Richard Andrew; Pettersson, Gosta B; Tonelli, AR (J Cardiovasc Pharmacol, 2014-04)
      Perioperative pulmonary hypertension can originate from an established disease or acutely develop within the surgical setting. Patients with increased pulmonary vascular resistance are consequently at greater risk ...
    • Pulmonary hypertension and elevated transpulmonary gradient in patients with mitral stenosis. 

      Bashore, TM; Harrison, JK; Hart, Stephen A; Kisslo, K; Krasuski, Richard Andrew; Wang, Andrew (J Heart Valve Dis, 2010-11)
      BACKGROUND AND AIM OF THE STUDY: Pulmonary hypertension frequently complicates mitral stenosis, with a subset of these patients exhibiting pressures well in excess of their mitral valve hemodynamics. The prevalence of this ...
    • Response to inhaled nitric oxide predicts survival in patients with pulmonary hypertension. 

      Bashore, TM; Devendra, Ganesh P; Harrison, JK; Hart, Stephen A; Krasuski, Richard Andrew; Wang, Andrew (J Card Fail, 2011-04)
      OBJECTIVE: To examine the ability of vasodilator response to predict survival in a diverse cohort of patients with pulmonary hypertension (PH). PATIENTS & METHODS: A total of 214 consecutive treatment-naive patients referred ...
    • Right-sided heart catheterization: de rigueur in sarcoidosis? 

      Culver, DA; Krasuski, Richard Andrew (Chest, 2010-11)
    • Treatment-related biomarkers in pulmonary hypertension. 

      Swaminathan, AC; Dusek, AC; McMahon, TJ (Am J Respir Cell Mol Biol, 2015-06)
      Significant advances in the treatment of pulmonary arterial hypertension (PAH) over the last two decades have led to the introduction of multiple classes of oral therapy, but the disease remains devastating for many patients. ...
    • Two Cases of Late Shone Syndrome With Pulmonary Hypertension: Heart-Lung Transplant or Valve Surgery? 

      Blackstone, Eugene H; Hanna, M; Krasuski, Richard Andrew; Pettersson, Gosta B; Robich, MP; Stewart, RD; Zahka, KG (World J Pediatr Congenit Heart Surg, 2016-01)
      Two cases of Shone syndrome with severe mitral and aortic valve problems and pulmonary hypertension were referred for heart-lung transplantation. Severely elevated pulmonary vascular resistance (PVR) was confirmed as was ...